Profound Medical Corp. Revenue 2023–2025
Profound Medical Corp. annual/quarterly revenue history and growth rate from 2023 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Profound Medical Corp. revenue for the quarter ending March 31, 2026 was 5.3 M, a 127.98% increase year-over-year.
- Profound Medical Corp. revenue for the twelve months ending March 31, 2026 was 14.7 M.
- Profound Medical Corp. annual revenue for 2025 was 16.1 M, a 65.28% increase from 2024.
- Profound Medical Corp. annual revenue for 2024 was 9.7 M, a 65.11% increase from 2023.
- Profound Medical Corp. annual revenue for 2023 was 5.9 M.
Profound Medical Corp. (PROF) — Frequently Asked Questions
Profound Medical Corp. (PROF) is a publicly traded US company. It has a market capitalization of $203M. In fiscal 2025 it reported revenue of $16M and net income of -$43M. Explore PROF's stock price, financial statements, earnings history, margins and key ratios below.
What is Profound Medical Corp.'s market cap?
Profound Medical Corp. (PROF) has a market capitalization of $203M.
What is the PROF stock price?
PROF trades at $6.71 (-1.61% on the day).
How much revenue does Profound Medical Corp. make?
Profound Medical Corp. reported revenue of $16M in fiscal 2025.
Is PROF profitable?
In fiscal 2025, Profound Medical Corp. reported net income of -$43M.